The oncogenic fusion protein DNAJB1-PRKACA can be specifically targeted by peptide-based immunotherapy in fibrolamellar hepatocellular carcinoma

DSpace Repository

The oncogenic fusion protein DNAJB1-PRKACA can be specifically targeted by peptide-based immunotherapy in fibrolamellar hepatocellular carcinoma

Author: Bauer, Jens; Koehler, Natalie; Maringer, Yacine; Bucher, Philip; Bilich, Tatjana; Zwick, Melissa; Dicks, Severin; Nelde, Annika; Dubbelaar, Marissa; Scheid, Jonas; Wacker, Marcel; Heitmann, Jonas J.; Schroeder, Sarah; Rieth, Jonas; Denk, Monika; Richter, Marion; Klein, Reinhild; Bonzheim, Irina; Luibrand, Julia; Holzer, Ursula; Ebinger, Martin; Brecht, Ines B.; Bitzer, Michael; Boerries, Melanie; Feucht, Judith; Salih, Helmut R.; Rammensee, Hans-Georg; Hailfinger, Stephan; Walz, Juliane S.
Tübinger Autor(en):
Bauer, Jens
Maringer, Yacine
Bucher, Philip
Bilich, Tatjana
Nelde, Annika
Scheid, Jonas
Wacker, Marcel
Rieth, Jonas
Denk, Monika
Richter, Marion
Klein, Reinhild
Bonzheim, Irina
Luibrand, Julia
Holzer, Ursula
Ebinger, Martin
Brecht, Ines B.
Bitzer, Michael
Feucht, Judith
Salih, Helmut R.
Rammensee, Hans-Georg
Hailfinger, Stephan
Walz, Juliane S.
Dubbelaar, Marissa L.
Heitmann, Jonas S.
Schröder, Sarah Marena
Published in: Nature Communications (2022), Bd. 13 (1), Article 6401
Verlagsangabe: Nature Portfolio
Language: English
Full text: http://dx.doi.org/10.1038/s41467-022-33746-3
ISSN: 2041-1723
DDC Classifikation: 500 - Natural sciences and mathematics
Dokumentart: Article
Show full item record

This item appears in the following Collection(s)